Torque Pharmaceuticals
Torque Pharmaceuticals is an Indian pharmaceutical company manufacturing medicines and health-care products across prescription, over-the-counter, nutritional, and personal-care categories.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Torque Pharmaceuticals is an Indian pharmaceutical company whose activities include the manufacture and export of medicines and related health-care products. Its production facilities are located at Issapur and Derabassi in Punjab and at Jharmajri and Baddi in Himachal Pradesh. The company’s product portfolio spans several therapeutic and consumer-health categories, including antibiotics, nutritional supplements, cough preparations, antipyretics, anti-inflammatory medicines, small-volume parenterals, dermatology products, and personal-care items. The business began in August 1985 as a partnership with a small initial investment. Its first manufacturing activity focused on oral liquid medicines, while tablet production was added in 1987. A significant expansion occurred in 1991 through the acquisition of Mac Brown, after which Torque entered small-volume parenteral production and began exporting to Uganda. The company subsequently expanded its manufacturing footprint and international distribution. A facility associated with Derabassi was established in 1994, and parenteral manufacturing began there in 2002. Exports to Mozambique and Angola also commenced in 2002. Quality and regulatory credentials became an important part of the company’s development. Torque received a WHO-GMP compliance certificate from drug regulators in 2005 and obtained ISO 9001:2000 certification in the same year. Its products were certified for export by Uganda’s National Drug Authority, and the company later received approval following inspection by Kenya’s Pharmacy and Poisons Board. A further manufacturing unit was added in Baddi in 2006, followed by an expansion in 2010 involving the acquisition of approximately 200,000 square feet of constructed area there. Torque has developed branded products in both pharmaceutical and consumer-facing categories. Its portfolio has included Torex cough syrup, Ketomac shampoo, No Scars, Canstat, Terbofin, Zincoa, and Ketomac Hair Oil. In 2011, several brands were acquired from Ochoa Labs, broadening its dermatology and personal-care presence. The company entered personal care more explicitly in 2012 with the launch of Ketomac Hair Oil. Its marketing has included the use of a recognized public figure: singer Jagjit Singh was selected as ambassador for Torex Cough Syrup in 2007. The company has also adjusted its distribution infrastructure. In 2013, it changed from a traditional distribution system to a direct distribution system, described in the source material as DTS. The stated commercial emphasis in the available reference material is on increasing sales volumes. Torque’s institutional affiliations and recognitions include participation in India’s pharmaceutical and chemicals export-promotion organizations and chambers of commerce, as well as recognition connected with manufacturing capability, financial strength, and regulatory certification. The available reference material does not establish a current parent company, ownership structure, stock-market listing, chief executive, official website, or precise corporate headquarters. Accordingly, those fields are left unspecified rather than inferred. The company’s documented export activity and regulatory approvals indicate an international operating footprint, but the available sources do not support a precise current market-by-market account.
History
Torque Pharmaceuticals was established as a partnership in August 1985. It began on a modest scale, producing oral liquid medicines, and expanded into tablet manufacturing in 1987. The business broadened its manufacturing and international profile in 1991 after acquiring Mac Brown. That transaction was followed by the start of small-volume parenteral production and exports to Uganda. The company continued building production capacity during the 1990s and early 2000s. A manufacturing unit was established at Derabassi in 1994. Parenteral manufacturing began there in 2002, the same year that Torque started exports to Mozambique and Angola. This period marked a transition from a primarily domestic manufacturing operation toward a business with documented African export markets. Quality systems and regulatory acceptance were central to the next phase of development. In 2005, Torque received a WHO-GMP compliance certificate from drug regulatory authorities and ISO 9001:2000 certification. Uganda’s National Drug Authority certified the company for medicine exports. In 2006, Torque added a manufacturing unit at Baddi in Himachal Pradesh. The company’s international regulatory reach expanded again in 2008, when Kenya’s Pharmacy and Poisons Board inspected its operations and subsequently approved the company. Torque increased its presence in branded and consumer-oriented categories during the late 2000s and early 2010s. In 2007, it promoted Torex Cough Syrup through a campaign featuring singer Jagjit Singh as brand ambassador. By 2010, the company had expanded its Baddi presence through the acquisition of approximately 200,000 square feet of constructed area. It also launched or promoted products including Ketomac Shampoo and No Scars. In 2011, it acquired Canstat, Terbofin, and Zincoa from Ochoa Labs, adding to its portfolio. Personal care became a more explicit segment in 2012 with the introduction of Ketomac Hair Oil. In 2013, Torque changed its logistics and distribution arrangement from a traditional distribution system to a direct distribution system. The available account presents this change as part of an effort to support sales-volume growth. Torque’s documented product categories include antibiotics, nutritional supplements, cough preparations, antipyretics, anti-inflammatory medicines, parenterals, dermatology products, and personal-care items. The available source identifies production sites and export destinations but does not provide enough current information to establish the company’s present ownership, executive leadership, listing status, headquarters, revenue, or detailed contemporary operations. Its documented history nevertheless shows a progression from oral-liquid production to a diversified pharmaceutical manufacturer with manufacturing expansion, quality certifications, branded product development, and exports to several African markets.
- 2013
Direct distribution adopted
[1]Torque changed its logistics network from a traditional distribution model to a direct distribution system.
- 2012
Ketomac Hair Oil launched
[1]The company expanded into personal care with Ketomac Hair Oil.
- 2011
Ochoa Labs brands acquired
[1]Canstat, Terbofin, and Zincoa were acquired from Ochoa Labs.
- 2010
Baddi facilities expanded
[1]Torque acquired approximately 200,000 square feet of constructed area in Baddi.
- 2008
Kenya regulatory approval
[1]Following inspection by Kenya’s Pharmacy and Poisons Board, Torque received approval there.
- 2007
Torex campaign with Jagjit Singh
[1]Singer Jagjit Singh was selected as ambassador for the Torex Cough Syrup campaign.
- 2006
Baddi unit added
[1]A further manufacturing unit was added in Baddi, Himachal Pradesh.
- 2005
WHO-GMP and ISO certification
[1]Torque received WHO-GMP compliance recognition and ISO 9001:2000 certification.
- 2002
Parenteral production and new African exports
[1]Parenteral manufacturing began at the Derabassi-related facility, while exports to Mozambique and Angola commenced.
- 1994
Derabassi manufacturing unit established
[1]The company established a manufacturing unit at Derabassi in northern India.
Products and positioning
An Indian pharmaceutical manufacturer and exporter combining prescription and over-the-counter medicines with nutritional, dermatology, and personal-care products.
Cough preparation
Torex Cough Syrup
A branded cough-syrup product associated with Torque’s consumer-health portfolio. The product received dedicated promotional support in 2007, when singer Jagjit Singh was selected as its brand ambassador.
Dermatology and personal care
Ketomac Shampoo
A branded shampoo included in Torque’s dermatology and personal-care range. It was among the products launched or promoted as the company broadened beyond core systemic medicines.
Dermatology and personal care
No Scars
A Torque brand associated with the company’s dermatology and personal-care offering. The available reference identifies the brand but does not provide a detailed formulation, indication, or current availability profile.
Pharmaceutical medicine · 2011
Canstat
A pharmaceutical brand acquired by Torque from Ochoa Labs in 2011. The available source confirms the acquisition but does not specify the product’s active ingredient, indication, or current market status.
Dermatology and pharmaceutical medicine · 2011
Terbofin
A brand acquired from Ochoa Labs in 2011 and incorporated into Torque’s broader pharmaceutical portfolio. Detailed product composition and current commercialization information are not provided in the available source.
Nutritional or pharmaceutical product · 2011
Zincoa
A brand acquired from Ochoa Labs in 2011. The reference material records the transaction but does not establish its precise formulation, therapeutic positioning, or current status.
Personal care · 2012
Ketomac Hair Oil
A personal-care product introduced as part of Torque’s move into hair-care products. Its launch represented an extension of the Ketomac name beyond the company’s shampoo offering.
Pharmaceutical medicines
Antibiotics
Torque’s documented product range includes antibiotics as a broad therapeutic category. Specific molecules, dosage forms, brands, and current registrations are not identified in the available reference.
Health supplements
Nutritional supplements
Nutritional supplements form part of the company’s stated product portfolio, alongside conventional medicines and consumer-health products. The available source does not list individual supplement formulations.
Parenteral medicines · 1991
Small-volume parenterals
Torque entered small-volume parenteral production after the 1991 Mac Brown acquisition and later began manufacturing parenterals at its Derabassi-related facility in 2002.
Marketing campaigns
- 2007Torex Cough Syrup ambassador campaign
India
Torque promoted Torex Cough Syrup through a campaign featuring singer Jagjit Singh as brand ambassador.
Outcome. The available source records the ambassador appointment but does not provide campaign performance results or spending data.
Brand decisions
2013
Move to direct distributionStrategyBackground
Torque was seeking to improve its logistics network and support growth in sales volumes.
Action taken
The company replaced its traditional distribution system with a direct distribution system.
Aftermath
The source identifies the distribution change but does not quantify its operational or financial effects.
2011
Acquisition of three Ochoa Labs brandsM&ABackground
Torque was broadening its branded product portfolio, including dermatology and related consumer-health categories.
Action taken
The company acquired Canstat, Terbofin, and Zincoa from Ochoa Labs.
Aftermath
The transaction added three named brands to Torque’s portfolio, although the available source does not describe later sales or market performance.
2002
Start of parenteral manufacturingProduct launchBackground
Torque had established a Derabassi manufacturing presence and was continuing to diversify its production base.
Action taken
The company began manufacturing parenterals and started exports to Mozambique and Angola.
Aftermath
Torque’s documented international footprint expanded beyond Uganda into additional African markets.
1991
Acquisition of Mac BrownM&ABackground
Torque sought to broaden its manufacturing capabilities and international business after its initial focus on oral liquids and tablets.
Action taken
The company acquired Mac Brown and subsequently entered small-volume parenteral manufacturing and Uganda exports.
Aftermath
The acquisition was followed by expanded product manufacturing and the company’s first documented export activity in Uganda.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/torque-pharmaceuticals · Editorial policy · How profiles are compiled